Comprehensive analyses of <i>N</i> <sup>6</sup> ‐methyladenosine‐related long noncoding <scp>RNA</scp> profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer-Reference-Cited by-同舟云学术

Comprehensive analyses of N ⁶ ‐methyladenosine‐related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer

Published:2022-09-15 Issue:12 Volume:113 Page:4289-4299
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Luo Yuejun¹²,Zhang Zhihui¹²,Zheng Bo³,Wu Peng¹²,Zhang Guochao¹²,Wang Lide¹²,Zeng Qingpeng¹²,Yang Zhaoyang³,Xue Liyan³,Zeng Hua³,Tan Fengwei¹,Xue Qi¹,Gao Shugeng¹,Sun Nan¹²,He Jie¹²^ORCID

Affiliation:

1. Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

3. Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15553

Reference36 articles.

1. Developing New, Rational Therapies for Recalcitrant Small Cell Lung Cancer

2. Small-cell lung cancer

3. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

4. Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124

5. Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 15-Gene-Based Risk Signature for Predicting Overall Survival in SCLC Patients Who Have Undergone Surgical Resection;Cancers;2023-10-30

2. The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer;Frontiers in Oncology;2023-03-09